Ronald J. Prentki

Ronald J. Prentki

Grundare på
Easton Healthcare Ventures LLC
68 år
Health Technology
Consumer Services
Consumer Non-Durables

Profil

Ronald J.
Prentki
is the founder of Easton Healthcare Ventures LLC, which was founded in 2005.
He currently holds the title of President at the company.
Mr. Prentki's former job positions include President & Chief Executive Officer at Heron Therapeutics, Inc. from 2008 to 2010, Director at Cardiovascular & Thoracic Surgeons of Greensboro PA, Manager-Anti Cancer Products at Bristol Myers Squibb Co. from 1985 to 1990, President at Progenics Pharmaceuticals, Inc. in 2005, VP-Business Development & Strategic Planning at Hoffmann-La Roche, Inc. in 1998, Vice President-Business Development at Sterling Drug, Inc. from 1990 to 1996, and Vice President-Business Development at Sanofi-Synthelabo, Inc. from 1990 to 1996.
Mr. Prentki's education history includes an undergraduate degree from Michigan State University and an MBA from the University of Detroit Mercy.

Aktiva positioner av Ronald J. Prentki

FöretagPositionStart
Easton Healthcare Ventures LLC
Grundare 2009-12-08

Tidigare kända positioner av Ronald J. Prentki

FöretagPositionSlut
HERON THERAPEUTICS, INC. President 2010-05-26
PROGENICS PHARMACEUTICALS, INC. President 2005-01-01
Företagsledare/Principal 1998-01-01
Företagsledare/Principal 1996-01-01
Sanofi-Synthelabo, Inc.
Företagsledare/Principal 1996-01-01
Se detaljerna i Ronald J. Prentkis erfarenhet

Ronald J. Prentkis utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

88

Första gradens relationer

10

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag10

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Non-Durables

Consumer Services

Sanofi-Synthelabo, Inc.

Health Technology

Easton Healthcare Ventures LLC

  1. Börsen
  2. Insiders
  3. Ronald J. Prentki
40% rabatt: De bästa verktygen för prenumeranter för att identifiera morgondagens bästa investeringar!
d
:
:
TA DEL AV DET NU